Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor

European Journal of Pharmacology

Volumn 396, Issue 2-3, 2000, Pages 141-149

  Buckley, Nancy E ^a   McCoy, Kathleen L ^b   Mezey, Éva ^a   Bonner, Tom ^c   Zimmer, Anne ^c   Felder, Christian C ^d   Glass, Michelle ^e   Zimmer, Andreas ^c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e National Institutes of DCD   (United States)

Author keywords

9Tetrahydrocannabinol; Cannabinoid receptor; Knockout mouse; Macrophage

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; DEXANABINOL; DRONABINOL; RECEPTOR SUBTYPE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BINDING SITE; CATALEPSY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FLUORESCENCE ACTIVATED CELL SORTER; GENE MUTATION; HELPER CELL; HYPOTHERMIA; HYPOTHESIS; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE;

ANIMALS; BODY TEMPERATURE; CATALEPSY; CYCLOHEXANOLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; T-LYMPHOCYTES; TETRAHYDROCANNABINOL;

EID: 0034685707     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00211-9     Document Type: Article

References (39)

1. Altman A., Coggeshall D.M., Mustelin T. Molecular events mediating T cell activation. Adv. Immunol. 48:1990;227-360.
2. 9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur. J. Pharmacol. 330:1997;231-240.
3. Bouaboula M., Rinaldi M., Carayon P., Carillon C., Delpech B., Shire D., Le Fur G., Casellas P. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214:1993;173-180.
4. 2: implication for intracellular signalization cross-regulation. Mol. Pharmacol. 55:1999;473-480.
5. 2 peripheral cannabinoid receptors during B-cell differentiation. Blood. 92:1998;3605-3615.
6. Chambers C.A., Allison J.P. Co-stimulation and T cell responses. Curr. Opin. Immunol. 9:1997;396-404.
7. Clements D.J., Cabral G.A., McCoy K.L. Delta 9-tetrahydrocannabinol selectively inhibits macrophage costimulatory activity and down-regulates heat-stable antigen expression. J. Pharmacol. Exp. Ther. 277:1996;1315-1321.
8. Clements D.J., Matveyeva M., McCoy K. Delta 9-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expression. Int. J. Immunopharmacol. 20:1998;415-428.
9. Daaka Y., Klein T.W., Friedman H. Expression of cannabinoid receptor mRNA in murine and human leukocytes. Adv. Exp. Med. Biol. 373:1995;91-96.
10. Derocq J.-M., Segui M., Marchand J., Le Fur G., Casellas P. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. 369:1995;177-182.
11. Enk A.H., Katz S.I. Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans cells. J. Immunol. 152:1994;3264-3270.
12. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
13. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:1994;287-299.
14. - T Cells replace B220+doble-negative T cells as the predominant populations in enlarged lymph nodes. J. Immunol. 154:1995;4986-4995.
15. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., deCosta B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
16. Hynes R.O. Versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
17. Janeway C.A. Jr., Bottomly K. Signals and signs for lymphocyte responses. Cell. 76:1994;275-285.
18. Kaye P.M., Rogers N.J., Curry A.J., Scott J.C. Deficient expression of costimulatory molecules on Leishmainia-infected macrophages. Eur. J. Immunol. 24:1994;2850-2854.
19. Klein T.W., Friedman H., Specter S. Marijuana, immunity and infection. J. Neuroimmunol. 83:1998;102-115.
20. Klein T.W., Newton C., Friedman H. Cannabinoid receptors and immunity. Immunol. Today. 19:1998;373-381.
21. Klein T.W., Newton C., Friedman H. Cannabinoid receptors and the cytokine network. Drugs of Abuse, Immunomodulation, and Aids. 1998;215-222 Plenum Press, New York.
22. 1 receptor knockout mice. Science. 283:1999;401-404.
23. Linsley P.S., Ledbetter J.A. The role of CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:1993;191-212.
24. Luo Y.D., Patel M.K., Wiederhold M.D., Ou D.W. Effects of cannabinoids and cocaine on the mitogen-induced transformation of lymphocytes of human and mouse origins. Int. J. Immunopharmacol. 14:1992;49-56.
25. Lynn A.B., Herkenham M. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J. Pharmacol. Exp. Ther. 268:1994;1612-1623.
26. Matsuda L., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
27. McCoy K.L., Gainey D., Cabral G.A. Delta-9-tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther. 273:1995;1216-1223.
28. 2 receptor participation. J. Pharmacol. Exp. Ther. 289:1999;1620-1625.
29. Mondino A., Jenkins M.K. Surface proteins involved in T cell costimulation. J. Leukocyte. Biol. 55:1994;805-815.
30. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
31. Portier M., Rinaldi-Carmona M., Pecceu F., Combes T., Poinot-Chazel C., Barth F., Fur G.L., Casellas P. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J. Pharmacol. Exp. Ther. 288:1999;582-589.
32. 9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators. Int. J. Immunopharmacol. 14:1992;1019-1027.
33. 2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284:1998;644650.
34. Saha B., Das G., Vohra H., Ganguly N.K., Mishra G.C. Macrophage-T cell interaction in experimental mycobacterial infection: selective regulation of costimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur. J. Immunol. 24:1994;2618-2624.
35. Samelson L.E., Germain R.E., Schwartz R.H. Monoclonal antibodies against the antigen receptor on a cloned T cell hybrid. Proc. Natl. Acad. Sci. U. S. A. 78:1983;6972-6976.
36. 2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142:1997;278-287.
37. Tybulewicz V.L., Crawford C.E., Jackson P.K., Bronson R.T., Mulligan R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 65:1991;1153-1163.
38. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:1997;821-850.
39. 1 receptor knockout mice. Proc. Natl. Acad. Sci. 96:1999;5780-5785.